Page last updated: 2024-09-02
tamibarotene and am 555s
tamibarotene has been researched along with am 555s in 2 studies
Compound Research Comparison
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (am 555s) | Trials (am 555s) | Recent Studies (post-2010) (am 555s) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 26 | 3 | 1 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hashimoto, Y; Kagechika, H; Kawachi, E; Shudo, K; Yamakawa, T | 1 |
| Igarashi, M; Kagechika, H; Shudo, K; Tateda, C; Yamazaki, N | 1 |
Other Studies
2 other study(ies) available for tamibarotene and am 555s
| Article | Year |
|---|---|
Retinobenzoic acids. 5. Retinoidal activities of compounds having a trimethylsilyl or trimethylgermyl group(s) in human promyelocytic leukemia cells HL-60.
Topics: Antineoplastic Agents; Benzoates; Cell Differentiation; Chemical Phenomena; Chemistry; Humans; Leukemia, Prolymphocytic; Organometallic Compounds; Silicon; Structure-Activity Relationship; Trimethylsilyl Compounds; Tumor Cells, Cultured | 1990 |
A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm.
Topics: Animals; Antibodies, Monoclonal; Avoidance Learning; Benzazepines; Benzoates; Dose-Response Relationship, Drug; Male; Memory Disorders; Nootropic Agents; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Retinoids; Scopolamine; Tetrahydronaphthalenes; Time Factors; Trimethylsilyl Compounds | 2004 |